Adenocarcinoma, Follicular - 36 Studies Found
| Terminated |
: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer :
|
| Completed |
: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer :
|
| Not yet recruiting |
: Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery :
|
| Active, not recruiting |
: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery :
|
| Completed |
: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer :
|
| Completed |
: Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer : Head and Neck Cancer : 1999-12-10 :
|
| Completed |
: Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer : Head and Neck Cancer : 2004-12-08 : Drug: rosiglitazone maleate |
| Completed |
: Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer : Head and Neck Cancer : 2003-06-05 : Drug: celecoxib Treatment will be administered on an outpatient basis. Oral celecoxib will be given at t |
| Active, not recruiting |
: Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid Cancer : Head and Neck Cancer : 2006-12-20 :
|
| Completed |
: Iodine I 131 in Treating Patients With Thyroid Cancer : Head and Neck Cancer : 2006-12-27 :
|